Genetics of CAD and its Vaccine Potential (Robert Roberts, MD)
Dr. Roberts describes the genetics of coronary artery disease and shows how this can be used as a polygenic risk factor to stratify CAD risk and identify tho…
Related Articles
Metsera, Maze secure combined $415 million in IPOs
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go public.
SABCS Snippets: FDA Approval of Dato-DXd
Hope S. Rugo, MD, of the University of California San Francisco, and Kate Lathrop, MD, SABCS Program Director, discuss the recent FDA approval of datopotamab…
Inconsistent Troponin Testing in US EDs Warrants Closer Look
New data from US centers suggest some overtesting in patients without chest pain, and undertesting in those who do.
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain | Vertex Pharmaceuticals Newsroom
— JOURNAVX is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than…
Smarter Healthcare Through Collaborative Intelligence
We’re thrilled to announce Season 2 of The Digital Healthcare Experience! Setting the bar high with Dr. Ami Bhatt, Chief Innovation Officer at the American…
Family shares story to spread stomach cancer awareness
Stomach cancer is claiming more lives, but awareness can make a difference. I sat down with a brave family on @9news to honor their loved…
Hiring! Immunology Postdoc
IMMUNOLOGY POSTDOC OPENING! Overview: We are seeking talented and enthusiastic postdoctoral scholars who have completed PhD or MD/PhD training, to join our lab focused on…
Frank J. Hildner, Founding Member of SCAI, Dies at 90
An early pioneer in the interventional community, Hildner advocated for sharing experiences to improve patient outcomes.
